Showing 181 - 190 of 399,584
an innovation rewarding institution. According to our analysis, pharma patents have constituted legal barriers to protect …
Persistent link: https://www.econbiz.de/10012604733
the proliferation of immunity-escaping variants. Therefore governmental rationality around the world would suggest any …
Persistent link: https://www.econbiz.de/10013254230
Persistent link: https://www.econbiz.de/10013258203
Persistent link: https://www.econbiz.de/10013036388
improve on counts in studies which require a measure of the extent of innovation. A simple renewal based weighting scheme is …
Persistent link: https://www.econbiz.de/10013213071
-effects regressions, this study yields robust results. National patent protection alone does not stimulate domestic innovation, as …, domestic innovation accelerates in countries with higher levels of economic development, educational attainment, and economic …
Persistent link: https://www.econbiz.de/10012751759
Persistent link: https://www.econbiz.de/10012795700
inventions". Some hold that protection is essential to encourage innovation and development of new products. Others argue that …
Persistent link: https://www.econbiz.de/10012441703
pharmaceutical patent protection alone does not stimulate domestic innovation, as estimated by the US patent awards (both raw counts … innovation acceleration and technology transfer, conditional upon certain country variables. In particular, the interaction …Research on the effects of patent protection on innovation and technology transfer in the cross-country pharmaceutical …
Persistent link: https://www.econbiz.de/10012462357
Persistent link: https://www.econbiz.de/10011998995